Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
about
Harnessing Mechanistic Knowledge on Beneficial Versus Deleterious IFN-I Effects to Design Innovative Immunotherapies Targeting Cytokine Activity to Specific Cell TypesType I interferon protects against pneumococcal invasive disease by inhibiting bacterial transmigration across the lungIFI16 protein mediates the anti-inflammatory actions of the type-I interferons through suppression of activation of caspase-1 by inflammasomesThe inflammasome: in memory of Dr. Jurg TschoppDICER1 loss and Alu RNA induce age-related macular degeneration via the NLRP3 inflammasome and MyD88Looking for Pyroptosis-Modulating miRNAs as a Therapeutic Target for Improving Myocardium SurvivalInflammasome/IL-1β Responses to Streptococcal PathogensNew Therapeutic Approaches in Polycythemia VeraTreating rheumatological diseases and co-morbidities with interleukin-1 blocking therapiesImmunomodulatory functions of type I interferonsInborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypesThe regulation of inflammation by interferons and their STATsDifferential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infectionsRegulation of inflammasome signalingInflammasomes: mechanism of action, role in disease, and therapeuticsNLRP3 inflammasome and its inhibitors: a reviewDecoding the complexity of type I interferon to treat persistent viral infectionsThe sst1 resistance locus regulates evasion of type I interferon signaling by Chlamydia pneumoniae as a disease tolerance mechanismActivation of the NLRP3 inflammasome by IAV virulence protein PB1-F2 contributes to severe pathophysiology and diseaseOpposing roles for interferon regulatory factor-3 (IRF-3) and type I interferon signaling during plagueRecent Advances of the NLRP3 Inflammasome in Central Nervous System DisordersThe inflammasome: an emerging therapeutic oncotarget for cancer preventionEffects of Interferons and Viruses on MetabolismNuclear factor E2-related factor-2 (Nrf2) is required for NLRP3 and AIM2 inflammasome activationThe PYRIN domain-only protein POP3 inhibits ALR inflammasomes and regulates responses to infection with DNA virusesAryl hydrocarbon receptor (AhR) regulates silica-induced inflammation but not fibrosisType I interferons promote fatal immunopathology by regulating inflammatory monocytes and neutrophils during Candida infectionsInflammasome adaptor protein Apoptosis-associated speck-like protein containing CARD (ASC) is critical for the immune response and survival in west Nile virus encephalitisInterferon-induced guanylate-binding proteins in inflammasome activation and host defenseActivation and regulation of the inflammasomesTo forge a solid immune recognition.Aim2 deficiency in mice suppresses the expression of the inhibitory Fcgamma receptor (FcgammaRIIB) through the induction of the IFN-inducible p202, a lupus susceptibility proteinThe p110δ isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock.Type I IFN suppresses Cxcr2 driven neutrophil recruitment into the sensory ganglia during viral infection.Type I Interferon Induction by Neisseria gonorrhoeae: Dual Requirement of Cyclic GMP-AMP Synthase and Toll-like Receptor 4.Type I interferon signaling regulates activation of the absent in melanoma 2 inflammasome during Streptococcus pneumoniae infection.Pathogenic potential of interferon αβ in acute influenza infectionTargeting the deubiquitinase STAMBP inhibits NALP7 inflammasome activity.Immunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosis.Down regulation of macrophage IFNGR1 exacerbates systemic L. monocytogenes infection
P2860
Q21131160-FE23D352-7D23-4030-8CFB-ED7DB73E3C35Q21131368-2F21BBD6-9EFE-42AA-AAD9-5F197517F32DQ24295265-A26F6F42-AC07-4723-AA40-9E064AD03B57Q24613816-015928F3-1CFA-40EB-A148-D82578DC1FBAQ24621930-A23D44B0-BFDC-4725-9DB1-385A74C51367Q26778539-A67204CE-E1A2-4937-BA6B-B5DB01463972Q26779173-4051613C-0AA0-4641-BC98-7E1D48C3C05EQ26795677-9096AA41-1ADF-4924-9764-0D65B8E19290Q26799747-FE7A6340-E166-46B5-9B36-CAFF14D49A66Q26823904-B0C10CFE-F406-45E3-80A6-43CD671164CAQ26825342-FB876E1E-9372-4B1E-B3CE-CB3361279CD8Q26829387-16BE8082-3166-44DD-94DF-AD3A2A551C23Q26849516-792106FE-D3E1-408F-B08F-2104B18BDDE8Q26996605-09EAD5B3-C038-4B3B-A36B-4F6B25A6449DQ27001186-34A4D580-1571-4028-A01F-10B25512ADACQ27023333-96BB6AAB-5313-4DD5-AEFC-1CB0DD8A1437Q27023801-6FBCF91C-A7D8-418C-853A-F40FCF9ECFA1Q27333845-1E6D4504-E7BD-4EB5-B36F-B3006C9D5D45Q27334659-9B211A86-2BE0-4BDA-A012-15FA73EA02B8Q27343051-412C9417-8533-4A9A-896E-90C195819F21Q28076650-596F47F5-F6BD-435B-A652-A7739BA219F3Q28076914-BF9EEAB2-71CA-44AB-BF6D-AFCDE3A0AD68Q28353943-4653D5EF-2FA6-44D9-A68B-3E2D334BC2CEQ28387955-19EDFABC-6913-4066-B6FC-04488B2D23D5Q28391800-2FECB4D3-E8D6-4CD8-8614-07B6D4BA8611Q28397728-F17082A8-3E11-4453-8436-0BFD68C18F2AQ28481589-AC4D0447-F0F9-4E53-863F-AE2BBBC002FAQ28593473-6D58E623-03A7-4F5D-B39B-23ED24DDCEB1Q28595838-18A1F5E2-2829-4EB2-92BC-ED0D52129553Q29615664-B93409B2-7D4D-47A0-A195-2E70041BF4A7Q30418305-BA14E444-5FE4-4D85-9601-FFAFA52D701FQ30426448-C826CA56-5AD1-462E-86A0-8107206E4EA6Q30577895-6A9B195F-C9C7-4F63-8627-E7E9F31859C5Q33569775-771FB149-CD51-42B3-A646-2D7231876376Q33592743-8DF2F6DD-5C9A-4ECB-A5B1-BAB7FD9F6FE0Q33602937-2091D11D-075D-43DA-8E18-049C38E305F9Q33663298-ADAE8FF9-F689-442E-9DC4-DFC3F9512D75Q33705575-4256B910-EC70-4187-AC75-368660505711Q33755345-4FC745A8-A283-4CE7-BE83-8BF3D73C6FA6Q33758400-34B4885B-7B0E-4D4B-93B6-A2B1F99199AE
P2860
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
@de
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
@en
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
@nl
type
label
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
@de
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
@en
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
@nl
prefLabel
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
@de
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
@en
Type I Interferon Inhibits Interleukin-1 Production and Inflammasome Activation
@nl
P2093
P50
P1433
P1476
Type I interferon inhibits interleukin-1 production and inflammasome activation
@en
P2093
Aubry Tardivel
Chantal Mattmann
Francesco Staehli
Jürg Tschopp
Marion Braun
Matthias Farlik
Pedro Romero
Thomas Decker
P304
P356
10.1016/J.IMMUNI.2011.02.006
P407
P577
2011-02-01T00:00:00Z